Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (‘J&J MedTech’), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 47…
l. The Company had no accrued warranties as of March 31, 2026, or December 31, 2025, and has no history of claims paid. 12 The Company is also involved from time-to-time in various legal proceedings …
Reciprocal relationship from JNJ graph: Reciprocal relationship from ANIK graph: l. The Company had no accrued warranties as of March 31, 2026, or December 31, 2025, and has no history of claims paid…
Anika Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ANIK-DEBT
Debt stack $25.7M
90%
Market cache reports total debt of $25.7M.
Anika Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Anika Therapeutics, Inc..
Anika Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
ANIK-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 129 tracked holders.
Anika Therapeutics, Inc. Extended Supply Chain Network